TITLE

CLINICAL TRIAL DIGEST

PUB. DATE
February 2011
SOURCE
Pulmonary Reviews;Feb2011, Vol. 16 Issue 2, p15
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses updates on newly published clinical trials for pulmonary disease treatment. A study in the 2011 issue of the "American Journal of Respiratory and Critical Care Medicine" recommends a written treatment plan with prescription for oral corticosteroids for children suffering from asthma. "Thorax" magazine's 2010 issue reports on 12 weeks of low dose erythromycin treatment for chronic cough. The 2011 "Archives of Internal Medicine" cites a study which recommends internet-based counseling for people who want to quit smoking.
ACCESSION #
58776131

 

Related Articles

  • Using exhaled NO concentrations to adjust inhaled corticosteroid dose maintained asthma control and reduced the dose. Smith, A. D.; Cowan, J. O.; Brassett, K. P.; Taylor, R. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20 

    The article reports on a study to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic asthma. Patients aged 12-75...

  • Chapter 15: Lessons learned from clinical trials of asthma. Sabin, Bradley R.; Avila, Pedro C.; Grammer, Leslie C.; Greenberger, Paul A. // Allergy & Asthma Proceedings;May/Jun2012 Supplement, Vol. 33, p51 

    The preponderance of clinical data suggest that inhaled corticosteroids (ICSs) are the preferred therapy for the long-term management of asthma, whereas oral or parental corticosteroids and short-acting beta2-adrenergic agonists remain the mainstay treatment of acute exacerbations. Allergen and...

  • Commentary. Rees, P. John // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p20 

    The article comments on a study by A. D. Smith and colleagues to determine whether optimizing the inhaled corticosteroid dose using the fraction of nitric oxide in exhaled air can reduce asthma exacerbations and the daily dosage compared to the use of standard criteria for patients with chronic...

  • Comparison of inhalant Fluticasone and Beclomethasone in treating mild and moderate persistent asthma in children. Issabeagloo, Eilyad; Aharchi, Taghi; Kermanizadeh, Parviz; Taghizadieh, Mohammad // Annals of Biological Research;2012, Vol. 3 Issue 3, p1536 

    Asthma is one of the most common diseases of childhood ages. Different medications are used in periods between asthma attacks that their principles are inhalant corticosteroids such as beclomethasone and fluticasone using fluticasone alone, can cause diminish in asthma symptoms in children and...

  • Review: inhaled corticosteroids reduce wheezing and asthma exacerbations in infants and preschool children. Renouf, Paula // Evidence Based Nursing;Oct2009, Vol. 12 Issue 4, p2 

    The article discusses a study on the use of inhaled corticosteroids (ICSs) in infants and preschool children with wheezing/asthma. Randomized controlled trials (RCTs) were conducted, with patients being given either ICS or placebo. Outcomes include increase severity of wheezing/asthma...

  • What is the optimal dose of inhaled corticosteroids in adult asthma? Chapman, Kenneth R. // Patient Care;2/1/1997, Vol. 31 Issue 2, p24 

    Focuses on the use of prescribe inhaled corticosteroids in higher doses to manage adult asthma. What is the optimal dose of inhaled corticosteroids in asthma; Explanations to be considered if patients with asthma do not respond well to dosages of inhaled corticosteroid under 1,000 a day; Why...

  • Inhaled vs. Systemic Corticosteroids in Asthma. Miller, Karl E. // American Family Physician;3/1/2003, Vol. 67 Issue 5, p1107 

    Presents a study that hypothesized that the use of high-dosage, inhaled corticosteroids in hospitalized asthma patients could be as well tolerated and effective as oral corticosteroids. Use of systemic corticosteroids in the treatment of hospitalized asthma patients; Advantages of using inhaled...

  • Systemic safety of fluticasone furoate/vilanterol combination. Lipworth, Brian; Busse, William W.; Andersen, Leslie // Thorax;Dec2013, Vol. 68 Issue 12, p1164 

    A letter to the editor related to an article on the safety of fluticasone furoate/vilanterol combination in asthma by W.W. Busse, P.M. O'Byrne and E.R. Bleecker in the 2013 issue is presented.

  • Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). Shrewsbury, Stephen; Pyke, Stephen; Britton, Mark // BMJ: British Medical Journal (International Edition);05/20/2000, Vol. 320 Issue 7246, p1368 

    Features a study which aimed to examine the benefits of adding salmeterol compared with increasing dose of inhaled corticosteroids in symptomatic asthma. Methodology of the study; Results and discussion; Conclusions.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics